Activation of DNA damage response signaling in lung adenocarcinoma A549 cells following oxygen beam irradiation

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 723, Issue 2, 2011, Pages 190-198

  Ghosh, Somnath ^a   Narang, Himanshi ^a   Sarma, Asiti ^b   Kaur, Harminder ^b   Krishna, Malini ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b INTER UNIVERSITY ACCELERATOR CENTRE   (India)

Author keywords

H2AX; ATM; ATR; Gamma; Oxygen

Indexed keywords

ATM PROTEIN; ATR PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; HISTONE H2AX; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER RADIOTHERAPY; CELL CYCLE ARREST; CELL SURVIVAL; CYTOTOXICITY; DNA DAMAGE; DNA REPAIR; GAMMA IRRADIATION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LUNG ADENOCARCINOMA; OXYGEN BEAM IRRADIATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADENOCARCINOMA; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; GAMMA RAYS; HISTONES; HUMANS; LINEAR ENERGY TRANSFER; LUNG NEOPLASMS; OXYGEN; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 79959690267     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2011.05.002     Document Type: Article

References (36)

1. Miyamoto T., Yamamoto N., Nishimura H., Koto M., Tsujii H., Mizoe J.E., Kamada T., Kato H., Yamada S., Morita S., Yoshikawa K., Kandatsu S., Fujisawa T. Carbon ion radiotherapy for stage I non-small cell lung cancer. Radiother. Oncol. 2003, 66:127-140.
2. Ogata T., Teshima T., Kagawa K., Hishikawa Y., Takahashi Y., Kawaguchi A., Suzumoto Y., Nojima K., Furusawa Y., Matsuura N. Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res. 2005, 65:113-120.
3. Schulz-Ertner D., Nikoghosyan A., Thilmann C., Haberer T., Jakel O., Karger C., Kraft G., Wannenmacher M., Debus J. Results of carbon ion radiotherapy in 152 patients. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:631-640.
4. Tsuji H., Ishikawa H., Yanagi T., Hirasawa N., Kamada T., Mizoe J.E., Kanai T., Tsujii H., Ohnishi Y. Carbon-ion radiotherapy for locally advanced or unfavorably located choroidal melanoma: a phase I/II dose-escalation study. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:857-862.
5. Durante M., Cucinotta F.A. Heavy ion carcinogenesis and human space exploration. Nat. Rev. Cancer 2008, 8:465-472.
6. Shibuya K., Mathers C.D., Boschi-Pinto C., Lopez A.D., Murray C.J. Global and regional estimates of cancer mortality and incidence by site. II. Results for the global burden of disease 2000. BMC Cancer 2002, 2:37.
7. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics2008. CA Cancer J. Clin. 2008, 58:71-96.
8. Ferlay J., Autier P., Boniol M., Heanue M., Colombet M., Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 2007, 18:581-592.
9. Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiother. Oncol. 2007, 83:203-213.
10. Kim Y.S., Yoon S.M., Choi E.K., Yi B.Y., Kim J.H., Ahn S.D., Lee S.W., Shin S.S., Lee J.S., Suh C., Kim S.W., Kim D.S., Kim W.S., Park H.J., Park C.I. Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62:76-81.
11. Farray D., Mirkovic N., Albain K.S. Multimodality therapy for stage III non-small-cell lung cancer. J. Clin. Oncol. 2005, 23:3257-3269.
12. Koto M., Miyamoto T., Yamamoto N., Nishimura H., Yamada S., Tsujii H. Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy. Radiother. Oncol. 2004, 71:147-156.
13. Pandita T.K., Lieberman H.B., Lim D.S., Dhar S., Zheng W., Taya Y., Kastan M.B. Ionizing radiation activates the ATM kinase throughout the cell cycle. Oncogene 2000, 19:1386-1391.
14. Kastan M.B., Lim D.S. The many substrates and functions of ATM. Nat. Rev. Mol. Cell. Biol. 2000, 1:179-186.
15. Maser R.S., Monsen K.J., Nelms B.E., Petrini J.H. hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell. Biol. 1997, 17:6087-6096.
16. Fernandez-Capetillo O., Lee A., Nussenzweig M., Nussenzweig A. H2AX: the histone guardian of the genome. DNA Repair (Amst.) 2004, 3:959-967.
17. Bekker-Jensen S., Lukas C., Kitagawa R., Melander F., Kastan M.B., Bartek J., Lukas J. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell. Biol. 2006, 173:195-206.
18. J.F. Ziegler, The Stopping and Range of Ions in Matter, http://www.srim.org/.
19. Ziegler J.F., Bierserk J.P., Littmark U. Stopping and Ranges of Ions in Matter 1985, Pergamon Press, New York.
20. Kraft G. Tumor therapy with heavy charged particles. Prog. Part. Nucl. Phys. 2000, 45:S473-S544.
21. Ghosh S., Bhat N.N., Santra S., Thomas R.G., Gupta S.K., Choudhury R.K., Krishna M. Low energy proton beam induces efficient cell killing in A549 lung adenocarcinoma cells. Cancer Invest. 2010, 28:615-622.
22. Rasband W.S. J.U.S. Image 1997-2006, National Institutes of Health, Bethesda, USA, http://rsb.info.nih.gov/ij/.
23. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
24. Olive P.L., Banath J.P. Phosphorylation of histone H2AX as a measure of radiosensitivity. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58:331-335.
25. Asaithamby A., Uematsu N., Chatterjee A., Story M.D., Burma S., Chen D.J. Repair of HZE-particle-induced DNA double-strand breaks in normal human fibroblasts. Radiat. Res. 2008, 169:437-446.
26. Avondoglio D., Scott T., Kil W.J., Sproull M., Tofilon P.J., Camphausen K. High throughput evaluation of gamma-H2AX. Radiat. Oncol. 2009, 4:31.
27. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 2000, 10:886-895.
28. Wang H., Zeng Z.C., Bui T.A., DiBiase S.J., Qin W., Xia F., Powell S.N., Iliakis G. Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res. 2001, 61:270-277.
29. Kurz E.U., Lees-Miller S.P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst.) 2004, 3:889-900.
30. Lakin N.D., Jackson S.P. Regulation of p53 in response to DNA damage. Oncogene 1999, 18:7644-7655.
31. Rich T., Allen R.L., Wyllie A.H. Defying death after DNA damage. Nature 2000, 407:777-783.
32. Zhang J., Willers H., Feng Z., Ghosh J.C., Kim S., Weaver D.T., Chung J.H., Powell S.N., Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol. Cell. Biol. 2004, 24:708-718.
33. Golding S.E., Rosenberg E., Khalil A., McEwen A., Holmes M., Neill S., Povirk L.F., Valerie K. Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells. J. Biol. Chem. 2004, 279:15402-15410.
34. Zafar F., Seidler S.B., Kronenberg A., Schild D., Wiese C. Homologous recombination contributes to the repair of DNA double-strand breaks induced by high-energy iron ions. Radiat. Res. 2010, 173:27-39.
35. Fei P., Bernhard E.J., El-Deiry W.S. Tissue-specific induction of p53 targets in vivo. Cancer Res. 2002, 62:7316-7327.
36. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 1991, 352:345-347.